An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

Local Institution - 0018, Bergamo

Local Institution - 0003, New York

Local Institution - 0010, New York

University Of Rochester, Rochester

Istituto Clinico Humanitas, Rozzano (milano)

Levine Cancer Institute, Charlotte

Bon Secours-St Francis Hosp, Greenville

Winship Cancer Institute., Atlanta

University Of Miami Sylvester Comprehensive Cancer Center, Miami

Local Institution - 0012, Tampa

Local Institution - 0024, Bologna

The Ohio State University Comprehensive Cancer Center, Columbus

Mayo Clinic, Rochester

University Of Chicago, Chicago

Washington University School Of Medicine, St Louis

Local Institution - 0020, Pierre-Bénite

Stephenson Cancer Center, Oklahoma City

Hopital Saint Louis, Paris

Providence Portland Medical Center, Portland

Local Institution - 0017, Birmingham

University of Washington - Seattle Cancer Care Alliance, Seattle

BC Cancer Agency - Vancouver Centre, Vancouver

Local Institution - 0011, Toronto

Jewish General Hospital, Montreal

Local Institution - 0027, Hospitalet de Llobregat - Barcelona

Churchill Hospital, Oxford

Royal Marsden Hospital, Sutton